Old Web
English
Sign In
Acemap
>
authorDetail
>
M. Graeser
M. Graeser
Bethesda Hospital
Oncology
Medicine
Internal medicine
early breast cancer
Chemotherapy
2
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
De-escalated neoadjuvant pertuzumab+trastuzumab with or without paclitaxel weekly in HR-/HER2+ early breast cancer: ADAPT-HR-/HER2+ biomarker and survival results.
2021
Journal of Clinical Oncology
Nadia Harbeck
Oleg Gluz
Matthias Christgen
S. Kuemmel
Eva Maria Grischke
Michael Braun
Jochem Potenberg
Katja Krauss
Claudia Schumacher
Helmut Forstbauer
Toralf Reimer
Andrea Stefek
Hans Holger Fischer
E. Pelz
M. Graeser
Christine Eulenburg
Ronald E. Kates
Rachel Wuerstlein
Hans Kreipe
Ulrike Nitz
Show All
Source
Cite
Save
Citations (3)
ADAPTcycle: Adjuvant dynamic marker-adjusted personalized therapy (ADAPT) comparing endocrine therapy plus ribociclib versus chemotherapy in intermediate-risk HR+/HER2- early breast cancer (EBC).
2019
Journal of Clinical Oncology
Nadia Harbeck
Oleg Gluz
Matthias Christgen
M. Graeser
Felix Hilpert
Katja Krauss
Marc Thill
Mathias Warm
Volkmar Müller
Michael Braun
Marianne Just
Hans Kreipe
Ulrike Nitz
Ronald E. Kates
Timo Schinkoethe
Rachel Wuerstlein
Sherko Kuemmel
Show All
Source
Cite
Save
Citations (1)
1